Arriva Pharmaceuticals, Inc. Forms Scientific Advisory Board
1/14/2009 11:13:18 AM
More...
|
Arriva Pharmaceuticals, Inc. Granted Protein Production Patent
10/1/2008 10:57:40 AM
More...
|
Arriva Pharmaceuticals, Inc. Granted Fusion Protein Patent
5/22/2008 8:50:14 AM
More...
|
Arriva Pharmaceuticals, Inc. Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT
2/28/2008 7:30:44 AM
More...
|
Arriva Pharmaceuticals, Inc. Appoints Marvin Garovoy, MD As Chief Medical Officer
10/19/2005 5:10:38 PM
More...
|
Arriva Pharmaceuticals, Inc. Announces Positive Data From Pre-Clinical Study Of Alpha 1-Antitrypsin To Prevent Lung Damage Caused By Smoking
10/19/2005 5:10:29 PM
More...
|
Baxter Healthcare Corporation (BAX) And Arriva Pharmaceuticals, Inc. Complete First Clinical Trial Evaluating The Safety And Tolerability Of Nebulized Recombinant Alpha 1-Antitrypsin
10/19/2005 5:10:12 PM
More...
|
Arriva Pharmaceuticals, Inc. Announces New Management And Board Members
10/19/2005 5:10:10 PM
More...
|
Arriva Pharmaceuticals, Inc. Names New General Counsel, Gregory J Ikonen
10/19/2005 5:09:12 PM
More...
|